Urinary prevalence, metabolite detection rates, temporal patterns and evaluation of suitable LC-MS/MS targets to document synthetic cannabinoid intake in US military urine specimens

Clinical Chemistry and Laboratory Medicine

Volumn 53, Issue 3, 2015, Pages 423-434

  Wohlfarth, Ariane ^a   Scheidweiler, Karl B ^a   Castaneto, Marisol ^a,b   Gandhi, Adarsh S ^a   Desrosiers, Nathalie A ^a,b   Klette, Kevin L ^c   Martin, Thomas M ^c   Huestis, Marilyn A ^a  

^a NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

^b UNIVERSITY OF MARYLAND   (United States)

^c Office of the under Secretary of Defense for Personnel and Readiness   (United States)

Author keywords

liquid chromatography tandem mass spectrometry (LC MS MS); metabolites; qualitative confirmation; synthetic cannabinoids; urine

Indexed keywords

1 (5 FLUOROPENTYL) 3 (1 NAPHTHOYL)INDOLE; 1 BUTYL 3 (1 NAPHTHOYL)INDOLE; 3 (1 NAPHTHOYL) 1 PENTYLINDOLE; ACETONITRILE; CANNABINOID DERIVATIVE; DRUG METABOLITE; JWH 081; JWH 122; JWH 200; JWH 210; JWH 250; MAM 2201; PSYCHEDELIC AGENT; RCS 4; UNCLASSIFIED DRUG; CANNABINOID;

ARMY; ARTICLE; CHEMICAL STRUCTURE; DECARBOXYLATION; DEFLUORINATION; DRUG METABOLISM; HUMAN; HYDROLYSIS; LABORATORY DIAGNOSIS; LIMIT OF DETECTION; LIQUID CHROMATOGRAPHY; MAJOR CLINICAL STUDY; PRECIPITATION; PRIORITY JOURNAL; QUALITATIVE ANALYSIS; TANDEM MASS SPECTROMETRY; TIME; UNITED STATES; URINALYSIS; EPIDEMIOLOGY; EVALUATION STUDY; IMMUNOASSAY; METABOLISM; PROCEDURES; SOLDIER; STATISTICS AND NUMERICAL DATA; SUBSTANCE ABUSE; URINE;

CANNABINOIDS; CHROMATOGRAPHY, LIQUID; HUMANS; IMMUNOASSAY; MILITARY PERSONNEL; MOLECULAR STRUCTURE; SUBSTANCE ABUSE DETECTION; TANDEM MASS SPECTROMETRY; TIME FACTORS; UNITED STATES;

EID: 84923105813     PISSN: 14346621     EISSN: 14374331     Source Type: Journal    
DOI: 10.1515/cclm-2014-0612     Document Type: Article

References (42)

1. Mackie K. Cannabinoid receptors: where they are and what they do. J Neuroendocrinol 2008;20:10-4.
2. US Government. Synthetic Drug Abuse Prevention Act of 2012. Food and Drug Administration Safety and Innovations Act Section 1152. 2012.
3. US Department of Justice. Schedules of controlled substances: temporary placement of four synthetic cannabinoids into Schedule I (XLR-11, UR-144, AKB48). Fed Regist 2013:28735-9.
4. US Department of Justice. Schedules of controlled substances: temporary placement of three synthetic cannabinoids into Schedule I (PB-22, 5F-PB-22, AB-FUBINACA, ADB-PINACA). Fed Regist 2014:1776-80.
5. Uchiyama N, Kikura-Hanajiri R, Ogata J, Goda Y. Chemical analysis of synthetic cannabinoids as designer drugs in herbal products. Forensic Sci Int 2010;198:31-8.
6. Kikura-Hanajiri R, Uchiyama N, Kawamura M, Goda Y. Changes in the prevalence of synthetic cannabinoids and cathinone derivatives in Japan until early 2012. Forensic Toxicol 2013;31:44-53.
7. Logan BK, Reinhold LE, Xu A, Diamond FX. Identification of synthetic cannabinoids in herbal incense blends in the United States. J Forensic Sci 2012;57:1168-80.
8. Uchiyama N, Kawamura M, Kikura-Hanajiri R, Goda Y. URB-754: a new class of designer drug and 12 synthetic cannabinoids detected in illegal products. Forensic Sci Int 2012;227:21-32.
9. Kneisel S, Westphal F, Rosner P, Brecht V, Ewald A, Klein B, et al. Cannabimimetics: mass spectra and IR-ATR spectra of new compounds from the years 2009 and 2010. TIAFT Bulletin 2011;41:38-49.
10. Auwärter V, Dresen S, Weinmann W, Müller M, Pütz M, Ferreirós N. 'Spice' and other herbal blends: harmless incense or cannabinoid designer drugs? J Mass Spectrom 2009;44:832-7.
11. Dresen S, Ferreiros N, Putz M, Westphal F, Zimmermann R, Auwärter V. Monitoring of herbal mixtures potentially containing synthetic cannabinoids as psychoactive compounds. J Mass Spectrom 2010;45:1186-94.
12. Uchiyama N, Matsuda S, Kawamura M, Kikura-Hanajiri R, Goda Y. Two new-type cannabimimetic quinolinyl carboxylates, QUPIC and QUCHIC, two new cannabimimetic carboxamide derivatives, ADB-FUBINACA and ADBICA, and five synthetic can-nabinoids detected with a thiophene derivative α-PVT and an opioid receptor agonist AH-7921 identified in illegal products. Forensic Toxicol 2013;31:223-40.
13. Uchiyama N, Matsuda S, Wakana D, Kikura-Hanajiri R, Goda Y. New cannabimimetic indazole derivaties, N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-pentyl-1H-indazole-3-carboxamide (AB-PINACA) and N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(4-fluorobenzyl)-1H-indazole-3-caboxamide (AB-FUBINACA) identified as designer drugs in illegal products. Forensic Toxicol 2013;31:93-100.
14. Chimalakonda KC, Bratton SM, Le VH, Yiew KH, Dineva A, Moran CL, et al. Conjugation of synthetic cannabinoids JWH-018 and JWH-073, metabolites by human UDP-glucuronosyltrans-ferases. Drug Metab Dispos 2011;39:1967-76.
15. Grigoryev A, Melnik A, Savchuk S, Simonov A, Rozhanets V. Gas and liquid chromatography-mass spectrometry studies on the metabolism of the synthetic phenylacetylindole cannabimimetic JWH-250, the psychoactive component of smoking mixtures. J Chromatogr B Analyt Technol Biomed Life Sci 2011;879:2519-26.
16. Grigoryev A, Savchuk S, Melnik A, Moskaleva N, Dzhurko J, Ershov M, et al. Chromatography-mass spectrometry studies on the metabolism of synthetic cannabinoids JWH-018 and JWH-073, psychoactive components of smoking mixtures. J Chroma-togr B Analyt Technol Biomed Life Sci 2011;879:1126-36.
17. Hutter M, Broecker S, Kneisel S, Auwärter V. Identification of the major urinary metabolites in man of seven synthetic cannabi-noids of the aminoalkylindole type present as adulterants in 'herbal mixtures' using LC-MS/MS techniques. J Mass Spectrom 2012;47:54-65.
18. Kavanagh P, Grigoryev A, Melnik A, Simonov A. The identification of the urinary metabolites of 3-(4-methoxybenzoyl)-1-pentylin-dole (RCS-4), a novel cannabimimetic, by gas chromatography-mass spectrometry. J Anal Toxicol 2012;36:303-11.
19. Sobolevsky T, Prasolov I, Rodchenkov G. Detection of urinary metabolites of AM-2201 and UR-144, two novel synthetic can-nabinoids. Drug Test Anal 2012;4:745-53.
20. Wohlfarth A, Pang S, Zhu M, Gandhi AS, Scheidweiler KB, Liu HF, et al. First metabolic profile of XLR-11, a novel synthetic cannabi-noid, obtained by using human hepatocytes and high-resolution mass spectrometry. Clin Chem 2013;59:1638-48.
21. Wohlfarth A, Gandhi A, Pang S, Zhu M, Scheidweiler K, Huestis M. Metabolism of synthetic cannabinoids PB-22 and its 5-fluoro analog, 5F-PB-22, by human hepatocyte incubation and high-resolution mass spectrometry. Anal Bioanal Chem 2014;406:1763-80.
22. Moran CL, Le VH, Chimalakonda KC, Smedley AL, Lackey FD, Owen SN, et al. Quantitative measurement of JWH-018 and JWH-073 metabolites excreted in human urine. Anal Chem 2011;83:4228-36.
23. Hutter M, Moosmann B, Kneisel S, Auwärter V. Characteristics of the designer drug and synthetic cannabinoid receptor agonist AM-2201 regarding its chemistry and metabolism. J Mass Spec-trom 2013;48:885-94.
24. American Association of Poison Control Centers. Synthetic Marijuana Data. 2013. Available from: http://www.aapcc.org/alerts/synthetic-marijuana/. Accessed 7 August, 2014.
25. University of Michigan. Monitoring the future drug press release: American teens more cautious about using synthetic drugs. 2013. Available from: http://www.monitoringthefuture.org//pressreleases/13drugpr-complete.pdf. Accessed 7 August, 2014.
26. Department of Defense. Instruction 1010.10: Military Personnel Drug Abuse Testing Program, 2012.
27. Secretary of the Army. Memorandum: prohibited substances (spice in variations). 2011.
28. Berry-Caban CS, Kleinschmidt PE, Rao DS, Jenkins J. Synthetic cannabinoid and cathinone use among US soldiers. US Army Med Dep J 2012:19-24.
29. Wohlfarth A, Scheidweiler KB, Chen X, Liu HF, Huestis MA. Qualitative confirmation of 9 synthetic cannabinoids and 20 metabolites in human urine using LC-MS/MS and library search. Anal Chem 2013;85:3730-8.
30. Jang M, Yang W, Shin I, Choi H, Chang H, Kim E. Determination of AM-2201 metabolites in urine and comparison with JWH-018 abuse. Int J Legal Med 2013;128:285-94.
31. Jang M, Yang W, Choi H, Chang H, Lee S, Kim E, et al. Monitoring of urinary metabolites of JWH-018 and JWH-073 in legal cases. Forensic Sci Int 2013;231:13-9.
32. Hermanns-Clausen M, Kneisel S, Hutter M, Szabo B, Auwärter V. Acute intoxication by synthetic cannabinoids-four case reports. Drug Test Anal 2013;5:790-4.
33. Jang M, Yang W, Shin I, Choi H, Chang H, Kim E. Determination of AM-2201 metabolites in urine and comparison with JWH-018 abuse. Int J Legal Med 2014;128:285-94.
34. Chimalakonda KC, Moran CL, Kennedy PD, Endres GW, Uzieblo A, Dobrowolski PJ, et al. Solid-phase extraction and quantitative measurement of omega and omega-1 metabolites of JWH-018 and JWH-073 in human urine. Anal Chem 2011;83:6381-8.
35. NMS Labs. Confirmed positive analytes in synthetic can-nabinoids blood samples 2013. Available from: http://www. nmslabs.com/uploads/PDF/Syn-Can-Graph.pdf. Accessed 7 August, 2014.
36. NMS Labs. Designer drug trends report August 2012: Synthetic cannabinoids, incense/smoking products 2012. Available from: http://www.nmslabs.com/uploads/PDF/Syn-Can-Graph.pdf. Accessed February, 2013.
37. De Brabanter N, Esposito S, Tudela E, Lootens L, Meuleman P, Leroux-Roels G, et al. In vivo and in vitro metabolism of the synthetic cannabinoid JWH-200. Rapid Commun Mass Spectrom 2013;27:2115-26.
38. Cayman Chemical. 2014. Available from: https://www.cayman-chem.com/. Accessed 7 August, 2014.
39. Scheidweiler KB, Huestis MA. Simultaneous quantification of 20 synthetic cannabinoids and 21 metabolites, and semi-quantification of 12 alkyl hydroxy metabolites in human urine by liquid chromatography-tandem mass spectrometry. J Chrom A 2014;1327:105-17.
40. Concheiro M, Anizan S, Ellefsen K, Huestis M. Simultaneous quantification of 28 synthetic cathinones and metabolites in urine by liquid chromatography-high resolution mass spectrom-etry. Anal Bioanal Chem 2013;405:9437-48.
41. Barlas F, Higgins W, Plfieger J, Diecker K. 2011 Department of Defense Health Related Behaviors Survey of Active Duty Military Personnel. Department of Defense, Fairfax, Virginia. Available from: http://www.murray.senate.gov/public/-cache/files/889efd07-2475-40ee-b3b0-508947957a0f/final-2011-hrb-active-duty-survey-report.pdf. Accessed 7 August, 2014.
42. Gould J. Spice crackdown: commanders get police powers. Army Times. Available from: http://www.armytimes.com/article/20130527/NEWS/305270010/Spice-crackdown-Commanders-get-police-powers. Accessed 7 August, 2014.